Renal Cancer - Results from #3800

Partial nephrectomy versus radical nephrectomy for large (≥ 7 cm) renal tumors: A systematic review and meta-analysis. February 12, 2019

Perioperative, oncological and functional outcomes after robotic partial nephrectomy vs. cryoablation in the elderly: A propensity score matched analysis. February 12, 2019

FDA Accepts sBLA and Grants Priority Review for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma February 12, 2019

Perioperative blood transfusion affects oncologic outcomes after nephrectomy for renal cell carcinoma: A systematic review and meta-analysis. February 11, 2019

Management of Older Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case Scenario. February 11, 2019

Identification of biomarkers of chromophobe renal cell carcinoma by weighted gene co-expression network analysis. February 11, 2019

Experience of Sorafenib as First-Line Treatment in Metastatic Renal Cell Carcinoma in a Tertiary Care Centre. February 8, 2019

Sources of Frustration Among Patients Diagnosed With Renal Cell Carcinoma. February 8, 2019

Health-related quality of life assessment for patients with advanced or metastatic renal cell carcinoma treated with a tyrosine kinase inhibitor using electronic patient-reported outcomes in daily clinical practice (QUANARIE trial): study protocol. February 8, 2019

Prospective clinical trial of 12-fraction carbon-ion radiotherapy for primary renal cell carcinoma. February 7, 2019

The Evolving Landscape of Immunotherapy-Based Combinations for Frontline Treatment of Advanced Renal Cell Carcinoma. February 7, 2019

Outcome of kidney function after ischaemic and zero-ischaemic laparoscopic and open nephron-sparing surgery for renal cell cancer. February 7, 2019

Renal Cancer Surgery for Patients without Preexisting Chronic Kidney Disease: Is there a Survival Benefit for Partial Nephrectomy? February 6, 2019

Interaction of germline variants in a family with a history of early-onset clear cell renal cell carcinoma. February 6, 2019

The correlation between the incidence of adverse events and progression-free survival in patients treated with cabozantinib for metastatic renal cell carcinoma (mRCC). February 6, 2019

Timing of brain metastases development in metastatic renal cell cancer patients treated with targeted therapies and survival outcomes: An Australian multicenter study. February 5, 2019

Comparative study of renal cell carcinoma in patients less than 40 years of age and older age patients: A retrospective single-center study. February 5, 2019

irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial. February 5, 2019

Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale. February 4, 2019

Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma. February 4, 2019

Page 191 of 456